Physician profile
Raphael Kellman
NPI 1124030044
$1,163.93
in general payments reported to CMS, 2019-2025
8 companies · $184 in 2025
The $184 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48.56 · 2020: $63.18 · 2021: $36.79 · 2022: $39.47 · 2023: $372 · 2024: $420 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $976.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $975.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $901.56 | 2019-2025 | Xifaxan, Trulance |
| Acella Pharmaceuticals, LLC | $91.86 | 2023-2025 | NP Thyroid 60 |
| Otsuka America Pharmaceutical, INC. | $48.19 | 2023-2024 | Rexulti, Abilify Asimtufii |
| Avion Pharmaceuticals | $40.67 | 2023-2024 | NP Thyroid 60 |
| Merz North America, INC. | $26.90 | 2019 | |
| Phadia US INC. | $19.41 | 2021 | |
| Ardelyx, INC. | $17.96 | 2024 | Ibsrela |
| Abbvie INC. | $17.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raphael Kellman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.